Why the study?
Does continuous levarterenol drip improve survival in patients with shock following myocardial infarction?
Does continuous levarterenol drip improve survival in patients with shock following myocardial infarction?
Prolonged use of levarterenol (over eight days) can result in patient survival in cases of shock following myocardial infarction.
Answers are grounded in this paper and cite their sources.
Survival after prolonged levarterenol for post-MI shock; hypothesis-generating and does not support routine use.
SURVEY the literature, to the best of my knowledge, has not revealed any case of shock following myocardial infarction treated with continuous levarterenol (Levophed) drip for over eight days with patient survival.* It is estimated that the mortality rate is between 80% and 90%⁷in sustained hypotension following myocardial infarction. The delayed gradual onset of shock has been described⁸as the clinical manifestation of progressive failure of the infarcted left ventricle and as almost invariably fatal. This is in contradistinction to the hypotension that may follow immediately after the onset of the infarct, in which case about 50% of the patients recover spontaneously within one hour. A 52-year-old well-nourished white women developed recurrent episodes of substernal pain of 24 hours' duration. Her husband had died of a brain tumor the preceding day. When first seen at home, she was lying in bed having recurrent attacks of anginal pain
No takes yet. Share an insight, caveat, or question.
IRVIN S. SIGLIN (1956) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: